{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:15:59Z","timestamp":1791314159905,"version":"4.3.1"},"reference-count":109,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.iac.2022.01.001","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:10:20Z","timestamp":1648746620000},"page":"433-452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pediatric Drug Allergy"],"prefix":"10.1016","volume":"42","author":[{"given":"Connor","family":"Prosty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Copaescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofianne","family":"Gabrielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Mule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Ben-Shoshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.iac.2022.01.001_bib1","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2013.09.021","article-title":"Health care use and serious infection prevalence associated with penicillin \"allergy\" in hospitalized patients: A cohort study","volume":"133","author":"Macy","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2022.01.001_bib2","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.jaip.2017.12.033","article-title":"The Cost of Self-Reported Penicillin Allergy: A Systematic Review","volume":"6","author":"Mattingly","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2022.01.001_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3345\/kjp.2019.00675","article-title":"Drug Allergy in Children: What Should We Know?","volume":"63","author":"Park","year":"2020","journal-title":"Clin Exp Pediatr"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/iid3.201","article-title":"Disparities in rate, triggers, and management in pediatric and adult cases of suspected drug-induced anaphylaxis in Canada","volume":"6","author":"Gabrielli","year":"2018","journal-title":"Immun Inflamm Dis"},{"issue":"8","key":"10.1016\/j.iac.2022.01.001_bib5","doi-asserted-by":"crossref","first-page":"778.e771","DOI":"10.1016\/j.amjmed.2009.01.034","article-title":"Self-reported Antibiotic Allergy Incidence and Prevalence: Age and Sex Effects","volume":"122","author":"Macy","year":"2009","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.iac.2022.01.001_bib6","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-2497","article-title":"Antibiotic Allergy in Pediatrics","volume":"141","author":"Norton","year":"2018","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.iac.2022.01.001_bib7","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1016\/j.jaip.2021.06.057","article-title":"Establishing amoxicillin allergy in children through direct graded oral challenge (GOC): evaluating risk factors for positive challenges, safety, and risk of cross reactivity to cephalosporines","volume":"9","author":"Exius","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.iac.2022.01.001_bib8","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/j.jaip.2019.05.038","article-title":"Cross-Reactivity to Cephalosporins and Carbapenems in Penicillin-Allergic Patients: Two Systematic Reviews and Meta-Analyses","volume":"7","author":"Picard","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.iac.2022.01.001_bib9","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.jaip.2020.11.063","article-title":"Cephalosporin Hypersensitivity: Descriptive Analysis, Cross-Reactivity, and Risk Factors","volume":"9","author":"Touati","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2022.01.001_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000495302","article-title":"The Diagnosis of Ceftriaxone Hypersensitivity in a Paediatric Population","volume":"178","author":"Mori","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"issue":"8","key":"10.1016\/j.iac.2022.01.001_bib11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1159\/000513974","article-title":"Evaluation of Clinical Properties and Diagnostic Test Results of Cephalosporin Allergy in Children","volume":"182","author":"Yilmaz Topal","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"issue":"4","key":"10.1016\/j.iac.2022.01.001_bib12","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jaip.2017.10.008","article-title":"Natural History of Benign Nonimmediate Allergy to Beta-Lactams in Children: A Prospective Study in Retreated Patients After a Positive and a Negative Provocation Test","volume":"6","author":"Tonson la Tour","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2022.01.001_bib13","doi-asserted-by":"crossref","first-page":"e160033","DOI":"10.1001\/jamapediatrics.2016.0033","article-title":"Assessing the Diagnostic Properties of a Graded Oral Provocation Challenge for the Diagnosis of Immediate and Nonimmediate Reactions to Amoxicillin in Children","volume":"170","author":"Mill","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"4","key":"10.1016\/j.iac.2022.01.001_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1399-3038.2011.01169.x","article-title":"Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests","volume":"22","author":"Ponvert","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"10.1016\/j.iac.2022.01.001_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/all.12774","article-title":"Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group","volume":"71","author":"Gomes","year":"2016","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.iac.2022.01.001_bib16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/oxfordjournals.aje.a115663","article-title":"Serum sickness in children after antibiotic exposure: Estimates of occurrence and morbidity in a health maintenance organization population","volume":"132","author":"Heckbert","year":"1990","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib17","first-page":"506","article-title":"Epidemiology of Severe Cutaneous Adverse Drug Reaction and Its HLA Association among Pediatrics","volume":"18","author":"Esmaeilzadeh","year":"2019","journal-title":"Iran J Pharm Res"},{"issue":"2","key":"10.1016\/j.iac.2022.01.001_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4168\/aair.2019.11.2.241","article-title":"Severe Cutaneous Adverse Reactions in Korean Pediatric Patients: A Study From the Korea SCAR Registry","volume":"11","author":"Oh","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.aller.2015.02.004","article-title":"Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS)","volume":"44","author":"Belver","year":"2016","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"2","key":"10.1016\/j.iac.2022.01.001_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/bcp.13445","article-title":"Is acetaminophen associated with a risk of Stevens-Johnson syndrome and toxic epidermal necrolysis? Analysis of the French Pharmacovigilance Database","volume":"84","author":"Lebrun-Vignes","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13223-020-00494-2","article-title":"Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology","volume":"16","author":"Jeimy","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2022.01.001_bib22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamainternmed.2020.0403","article-title":"Development and Validation of a Penicillin Allergy Clinical Decision Rule","volume":"180","author":"Trubiano","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/pai.12493","article-title":"Direct oral provocation tests in non-immediate mild cutaneous reactions related to beta-lactam antibiotics","volume":"27","author":"Vezir","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"10.1016\/j.iac.2022.01.001_bib24","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jaip.2020.08.047","article-title":"Differentiating Between \u03b2-Lactam-Induced Serum Sickness-Like Reactions and Viral Exanthem in Children Using a Graded Oral Challenge","volume":"9","author":"Delli Colli","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2022.01.001_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug Allergy: An Updated Practice Parameter","volume":"105","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaci.2010.08.025","article-title":"The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge","volume":"127","author":"Caubet","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2022.01.001_bib27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1542\/peds.2007-3178","article-title":"Diagnosing Hypersensitivity Reactions to Cephalosporins in Children","volume":"122","author":"Romano","year":"2008","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.iac.2022.01.001_bib28","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/all.12182","article-title":"Validation of the cephalosporin intradermal skin test for predicting immediate hypersensitivity: a prospective study with drug challenge","volume":"68","author":"Yoon","year":"2013","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.iac.2022.01.001_bib29","doi-asserted-by":"crossref","first-page":"AB195","DOI":"10.1016\/j.jaci.2018.12.596","article-title":"Diagnosis Of Cephalosporin Allergy Through Graded Oral Challenge","volume":"143","author":"Attari","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.anai.2014.04.017","article-title":"Skin testing only with penicillin G in children with a history of penicillin allergy","volume":"113","author":"Picard","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/pai.12001","article-title":"Desensitization to antibiotics in children","volume":"24","author":"Cernadas","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"10.1016\/j.iac.2022.01.001_bib32","first-page":"134","article-title":"Tolerance to cephalosporins in nonimmediate hypersensitivity to penicillins in pediatric patients","volume":"24","author":"Callero","year":"2014","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"3-S","key":"10.1016\/j.iac.2022.01.001_bib33","first-page":"11","article-title":"A\u00a0practical management of children with antibiotic allergy","volume":"90","author":"Calamelli","year":"2019","journal-title":"Acta Biomed"},{"issue":"2","key":"10.1016\/j.iac.2022.01.001_bib34","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/cea.12468","article-title":"Management of allergy to penicillins and other beta-lactams","volume":"45","author":"Mirakian","year":"2015","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaip.2017.08.027","article-title":"Cross-reactivity in \u03b2-Lactam Allergy","volume":"6","author":"Zagursky","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.iac.2022.01.001_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000501518","article-title":"Antibiotic Allergy in Children: More than Just a Label","volume":"180","author":"Abrams","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"10.1016\/j.iac.2022.01.001_bib37","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1345\/aph.1L486","article-title":"Allergic cross-sensitivity between penicillin, carbapenem, and monobactam antibiotics: what are the chances?","volume":"43","author":"Frumin","year":"2009","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.iac.2022.01.001_bib38","doi-asserted-by":"crossref","first-page":"266","DOI":"10.7326\/0003-4819-146-4-200702200-00005","article-title":"Brief communication: tolerability of meropenem in patients with IgE-mediated hypersensitivity to penicillins","volume":"146","author":"Romano","year":"2007","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.iac.2022.01.001_bib39","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.anai.2020.03.012","article-title":"Children with reported penicillin allergy: Public health impact and safety of delabeling","volume":"124","author":"Vyles","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.iac.2022.01.001_bib40","first-page":"106","article-title":"Cephalosporins can be prescribed safely for penicillin-allergic patients","volume":"55","author":"Pichichero","year":"2006","journal-title":"J\u00a0Fam Pract"},{"issue":"3-s","key":"10.1016\/j.iac.2022.01.001_bib41","first-page":"20","article-title":"Drug desensitization in allergic children","volume":"90","author":"Caimmi","year":"2019","journal-title":"Acta Biomed"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/1744666X.2019.1698294","article-title":"Protocols for drug allergy desensitization in children","volume":"16","author":"Diaferio","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2022.01.001_bib43","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0091-6749(82)80004-3","article-title":"Desensitization of patients allergic to penicillin using orally administered beta-lactam antibiotics","volume":"69","author":"Sullivan","year":"1982","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2022.01.001_bib44","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0091-6749(87)90371-X","article-title":"Acute and chronic desensitization of penicillin-allergic patients using oral penicillin","volume":"79","author":"Stark","year":"1987","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"16","key":"10.1016\/j.iac.2022.01.001_bib45","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/ajhp\/59.16.1532","article-title":"Simple intravenous antimicrobial desensitization method for pediatric patients","volume":"59","author":"De Maria","year":"2002","journal-title":"Am J Health Syst Pharm"},{"issue":"3\u20134","key":"10.1016\/j.iac.2022.01.001_bib46","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000488857","article-title":"Hospitalizations in Children with a Penicillin Allergy Label: An Assessment of Healthcare Impact","volume":"176","author":"Sousa-Pinto","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.iac.2022.01.001_bib47","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1017\/ice.2020.424","article-title":"The impact of beta-lactam allergy labels on hospitalized children","volume":"42","author":"Jones","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.iac.2022.01.001_bib48","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaip.2013.01.006","article-title":"Treatment of patients with a history of penicillin allergy in a large tertiary-care academic hospital","volume":"1","author":"Picard","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2022.01.001_bib49","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.acap.2019.01.002","article-title":"Reported Knowledge and Management of Potential Penicillin Allergy in Children","volume":"19","author":"Vyles","year":"2019","journal-title":"Acad Pediatr"},{"issue":"2","key":"10.1016\/j.iac.2022.01.001_bib50","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jama.2018.19283","article-title":"Evaluation and Management of Penicillin Allergy: A Review","volume":"321","author":"Shenoy","year":"2019","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.iac.2022.01.001_bib51","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2500\/aap.2012.33.3510","article-title":"Outpatient penicillin use after negative skin testing and drug challenge in a pediatric population","volume":"33","author":"Picard","year":"2012","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"10.1016\/j.iac.2022.01.001_bib52","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.anai.2016.01.018","article-title":"Impact of an extended challenge on the effectiveness of \u03b2-lactam hypersensitivity investigation","volume":"116","author":"Ratzon","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"10.1016\/j.iac.2022.01.001_bib53","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/INF.0000000000002664","article-title":"Trimethoprim-Sulfamethoxazole Associated Drug-Induced Liver Injury in Pediatrics: A Systematic Review","volume":"39","author":"Burgos","year":"2020","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.iac.2022.01.001_bib54","first-page":"128","article-title":"Azithromycin is more allergenic than clarithromycin in children with suspected hypersensitivity reaction to macrolides","volume":"25","author":"Barni","year":"2015","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2022.01.001_bib55","first-page":"148","article-title":"Pharmacokinetic properties of clarithromycin: A comparison with erythromycin and azithromycin","volume":"4","author":"Lebel","year":"1993","journal-title":"Can J Infect Dis"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000443830","article-title":"Proven Non-\u03b2-Lactam Antibiotic Allergy in Children","volume":"169","author":"Guvenir","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.10.003","article-title":"Allergy to sulfonamides","volume":"131","author":"Schnyder","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2022.01.001_bib58","article-title":"Aminoglycoside Allergic Reactions","volume":"7","author":"Childs-Kean","year":"2019","journal-title":"Pharmacy (Basel)"},{"issue":"2","key":"10.1016\/j.iac.2022.01.001_bib59","article-title":"Glycopeptide Hypersensitivity and Adverse Reactions","volume":"8","author":"Huang","year":"2020","journal-title":"Pharmacy (Basel)."},{"issue":"5","key":"10.1016\/j.iac.2022.01.001_bib60","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaad.2017.05.041","article-title":"Vancomycin and DRESS: A retrospective chart review of 32 cases in Los Angeles, California","volume":"77","author":"Lam","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib61","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-2256","article-title":"Non-\u03b2-Lactam Antibiotic Hypersensitivity Reactions","volume":"145","author":"Grinlington","year":"2020","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.iac.2022.01.001_bib62","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/pai.13588","article-title":"Clarithromycin hypersensitivity in children: Is there a link with \u03b2-lactam hypersensitivity?","volume":"32","author":"Suleyman","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"issue":"5","key":"10.1016\/j.iac.2022.01.001_bib63","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.anai.2010.03.010","article-title":"Sensitivity and specificity of skin tests in the diagnosis of clarithromycin allergy","volume":"104","author":"Mori","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"10.1016\/j.iac.2022.01.001_bib64","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.jaip.2019.05.034","article-title":"Sulfonamide Hypersensitivity: Fact and Fiction","volume":"7","author":"Khan","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.iac.2022.01.001_bib65","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaip.2019.07.003","article-title":"Oral challenge with trimethoprim-sulfamethoxazole in patients with \"sulfa\" antibiotic allergy","volume":"8","author":"Krantz","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib66","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1939-4551-6-18","article-title":"Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy","volume":"6","author":"S\u00e1nchez-Borges","year":"2013","journal-title":"World Allergy Organ J"},{"issue":"6","key":"10.1016\/j.iac.2022.01.001_bib67","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.anai.2020.02.007","article-title":"Hypersensitivity to tetracyclines: Skin testing, graded challenge, and desensitization regimens","volume":"124","author":"Maciag","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib68","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2222.2007.02870.x","article-title":"Drug allergy claims in children: from self-reporting to confirmed diagnosis","volume":"38","author":"Rebelo Gomes","year":"2008","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib69","first-page":"59","article-title":"Provocation proven drug allergy in Thai children with adverse drug reactions","volume":"34","author":"Indradat","year":"2016","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"3","key":"10.1016\/j.iac.2022.01.001_bib70","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.anai.2014.06.019","article-title":"Multinational experience with hypersensitivity drug reactions in Latin America","volume":"113","author":"Jares","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib71","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2222.2010.03651.x","article-title":"Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response","volume":"41","author":"Dona","year":"2011","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.iac.2022.01.001_bib72","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jaip.2019.10.049","article-title":"A\u00a0Multicenter Retrospective Study on Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Children: A Report from the European Network on Drug Allergy (ENDA) Group","volume":"8","author":"Mori","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2022.01.001_bib73","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11096-015-0100-9","article-title":"Diagnostic evaluation and risk factors for drug allergies in children: from clinical history to skin and challenge tests","volume":"37","author":"Arikoglu","year":"2015","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib74","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13052-019-0753-4","article-title":"Epidemiology and drug allergy results in children investigated in allergy unit of a tertiary-care paediatric hospital setting","volume":"46","author":"Piccorossi","year":"2020","journal-title":"Ital J Pediatr"},{"issue":"3","key":"10.1016\/j.iac.2022.01.001_bib75","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.alit.2016.10.004","article-title":"Discrepancies in the diagnosis and classification of nonsteroidal anti-inflammatory drug hypersensitivity reactions in children","volume":"66","author":"Arikoglu","year":"2017","journal-title":"Allergol Int"},{"issue":"2","key":"10.1016\/j.iac.2022.01.001_bib76","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.anai.2020.04.003","article-title":"Results of NSAID provocation tests and difficulties in the classification of children with nonsteroidal anti-inflammatory drug hypersensitivity","volume":"125","author":"Yilmaz Topal","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.iac.2022.01.001_bib77","first-page":"561","article-title":"Hypersensitivity to cyclooxygenase inhibitory drugs in children: a study of 164 cases","volume":"18","author":"Hassani","year":"2008","journal-title":"Eur J Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib78","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/cea.12013","article-title":"Value of the clinical history in the diagnosis of urticaria\/angioedema induced by NSAIDs with cross-intolerance","volume":"43","author":"Blanca-Lopez","year":"2013","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1081-1206(10)62748-2","article-title":"Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity","volume":"84","author":"Sanchez-Borges","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"10.1016\/j.iac.2022.01.001_bib80","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/all.12266","article-title":"Challenge-proven nonsteroidal anti-inflammatory drug hypersensitivity in children","volume":"68","author":"Yilmaz","year":"2013","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2022.01.001_bib81","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000438992","article-title":"Different Phenotypes of Non-Steroidal Anti-Inflammatory Drug Hypersensitivity during Childhood","volume":"167","author":"Cavkaytar","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"issue":"7","key":"10.1016\/j.iac.2022.01.001_bib82","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/pai.12596","article-title":"Phenotypical characterization of children with hypersensitivity reactions to NSAIDs","volume":"27","author":"Cousin","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"issue":"8","key":"10.1016\/j.iac.2022.01.001_bib83","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/pai.12020","article-title":"Diagnosing multiple drug hypersensitivity in children","volume":"23","author":"Atanaskovic-Markovic","year":"2012","journal-title":"Pediatr Allergy Immunol"},{"issue":"6","key":"10.1016\/j.iac.2022.01.001_bib84","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.aller.2015.01.005","article-title":"Actual drug allergy during childhood: Five years' experience at a tertiary referral centre","volume":"43","author":"Tugcu","year":"2015","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib85","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2500\/aap.2016.37.3917","article-title":"The value of the clinical history for the diagnosis of immediate nonsteroidal anti-inflammatory drug hypersensitivity and safe alternative drugs in children","volume":"37","author":"Topal","year":"2016","journal-title":"Allergy Asthma Proc"},{"issue":"7","key":"10.1016\/j.iac.2022.01.001_bib86","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/pai.12286","article-title":"Negative predictive value of drug provocation tests in children","volume":"25","author":"Misirlioglu","year":"2014","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"10.1016\/j.iac.2022.01.001_bib87","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2500\/aap.2020.41.200032","article-title":"Negative predictive value of provocation tests for nonsteroidal anti-inflammatory drugs in children","volume":"41","author":"Topal","year":"2020","journal-title":"Allergy Asthma Proc"},{"issue":"11","key":"10.1016\/j.iac.2022.01.001_bib88","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/j.1398-9995.2011.02684.x","article-title":"Response to a selective COX-2 inhibitor in patients with urticaria\/angioedema induced by nonsteroidal anti-inflammatory drugs","volume":"66","author":"Do\u00f1a","year":"2011","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2022.01.001_bib89","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/bjd.12674","article-title":"Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugs","volume":"170","author":"Corzo","year":"2014","journal-title":"Br J Dermatol"},{"issue":"Suppl 3","key":"10.1016\/j.iac.2022.01.001_bib90","first-page":"S85","article-title":"Stevens-Johnson syndrome in Thai children: a 29-year study","volume":"94","author":"Singalavanija","year":"2011","journal-title":"J\u00a0Med Assoc Thai"},{"issue":"9","key":"10.1016\/j.iac.2022.01.001_bib91","first-page":"4537","article-title":"Stevens-Johnson syndrome and acute vanishing bile duct syndrome after the use of amoxicillin and naproxen in a child","volume":"47","author":"Li","year":"2019","journal-title":"J\u00a0Int Med Res"},{"issue":"3","key":"10.1016\/j.iac.2022.01.001_bib92","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaip.2017.02.013","article-title":"Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study","volume":"5","author":"Dibek Misirlioglu","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib93","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/cea.13513","article-title":"Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9-year experience in a tertiary care paediatric hospital setting","volume":"50","author":"Liccioli","year":"2020","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib94","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1574886310666150921103852","article-title":"A\u00a0Case of Toxic Epidermal Necrolysis Secondary to Acetaminophen in a Child","volume":"11","author":"Pena","year":"2016","journal-title":"Curr Drug Saf"},{"issue":"3","key":"10.1016\/j.iac.2022.01.001_bib95","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5152\/TurkPediatriArs.2016.3836","article-title":"Evaluation of the patients diagnosed with Stevens Johnson syndrome and toxic epidermal necrolysis: a single center experience","volume":"51","author":"Cekic","year":"2016","journal-title":"Turk Pediatri Ars"},{"issue":"5","key":"10.1016\/j.iac.2022.01.001_bib96","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jaad.2020.03.081","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) in the pediatric population: A systematic review of the literature","volume":"83","author":"Kim","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2022.01.001_bib97","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5114\/pdia.2014.43881","article-title":"Cutaneous drug reactions in children: a multicentric study","volume":"31","author":"Dilek","year":"2014","journal-title":"Postepy Dermatol Alergol"},{"issue":"3","key":"10.1016\/j.iac.2022.01.001_bib98","first-page":"197","article-title":"Association of HLA genotypes with Beta-lactam antibiotic hypersensitivity in children","volume":"39","author":"Singvijarn","year":"2021","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"10","key":"10.1016\/j.iac.2022.01.001_bib99","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/cid\/ciu126","article-title":"Severe cutaneous adverse reactions related to systemic antibiotics","volume":"58","author":"Lin","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.iac.2022.01.001_bib100","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1136\/archdischild-2013-303718","article-title":"A\u00a0review of causes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children","volume":"98","author":"Ferrandiz-Pulido","year":"2013","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib101","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/bjd.17841","article-title":"British Association of Dermatologists' guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in children and young people, 2018","volume":"181","author":"McPherson","year":"2019","journal-title":"Br J Dermatol"},{"issue":"1928","key":"10.1016\/j.iac.2022.01.001_bib102","first-page":"11","article-title":"An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity","author":"Copaescu","year":"2021","journal-title":"Front Pharmacol"},{"issue":"36","key":"10.1016\/j.iac.2022.01.001_bib103","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.2174\/1381612825666191107104126","article-title":"Role of in\u00a0vivo and in\u00a0vitro Tests in the Diagnosis of Severe Cutaneous Adverse Reactions (SCAR) to Drug","volume":"25","author":"Bergmann","year":"2019","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib104","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0536.2009.01659.x","article-title":"Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS)","volume":"62","author":"Santiago","year":"2010","journal-title":"Contact Derm"},{"issue":"1","key":"10.1016\/j.iac.2022.01.001_bib105","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jaip.2020.08.012","article-title":"Early high-dose intravenous corticosteroids rapidly arrest Stevens Johnson syndrome and drug reaction with eosinophilia and systemic symptoms recurrence on drug re-exposure","volume":"9","author":"Lehloenya","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.iac.2022.01.001_bib106","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1016\/j.jaip.2021.04.073","article-title":"Direct Challenges for the Evaluation of Beta-Lactam Allergy: Evidence and Conditions for Not Performing Skin Testing","volume":"9","author":"Iammatteo","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.iac.2022.01.001_bib107","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.anai.2018.05.013","article-title":"Prospective assessment of diagnostic tests for pediatric penicillin allergy: From clinical history to challenge tests","volume":"121","author":"Ib\u00e1\u00f1ez","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"10.1016\/j.iac.2022.01.001_bib108","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/cea.12596","article-title":"Utility of skin testing in children with a history of non-immediate reactions to amoxicillin","volume":"45","author":"Barni","year":"2015","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.iac.2022.01.001_bib109","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2500\/aap.2020.41.200082","article-title":"Diagnostic value and safety of penicillin skin tests in children with immediate penicillin allergy","volume":"41","author":"Kulhas Celik","year":"2020","journal-title":"Allergy Asthma Proc"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856122000017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856122000017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:45:09Z","timestamp":1760179509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856122000017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":109,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0889856122000017"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2022.01.001","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Drug Allergy","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2022.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}